|
Adam Heller is an Israeli-American engineer and Research Professor of the John J. McKetta Department of Chemical Engineering at the University of Texas at Austin. He formerly held the Ernest Cockrell Sr. Chair in Engineering of the Cockrell School of Engineering at the University of Texas. As of 2013, he was granted 209 US patents with 350 patent applications pending. He consults to Abbott Diabetes Care, Inc. of Alameda, CA, the maker of the Freestyle line of products. He also serves as Chief Scientific Officer of Synagile Corporation, a venture developing continuous infusion systems for managing Parkinson's disease.
|
